Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
15.83
+0.47 (3.06%)
Nov 22, 2024, 4:00 PM EST - Market closed
Tyra Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 21.49 | 17.43 | 15.92 | 5.65 | 2.09 | 1.33 |
| Research & Development | 78.57 | 62.52 | 43.01 | 20.64 | 7.2 | 1.79 |
| Operating Expenses | 100.07 | 79.95 | 58.93 | 26.29 | 9.3 | 3.12 |
| Operating Income | -100.07 | -79.95 | -58.93 | -26.29 | -9.3 | -3.12 |
| Interest Expense | - | - | - | - | -0 | -0 |
| Interest & Investment Income | 16.37 | 10.85 | 3.65 | 0.01 | - | - |
| Other Non Operating Income (Expenses) | -0.04 | -0.04 | -0.05 | -0.02 | -0.04 | -0.94 |
| Pretax Income | -83.74 | -69.13 | -55.33 | -26.29 | -9.34 | -4.07 |
| Net Income | -83.74 | -69.13 | -55.33 | -26.29 | -9.34 | -4.07 |
| Net Income to Common | -83.74 | -69.13 | -55.33 | -26.29 | -9.34 | -4.07 |
| Shares Outstanding (Basic) | 53 | 43 | 42 | 14 | 2 | 3 |
| Shares Outstanding (Diluted) | 53 | 43 | 42 | 14 | 2 | 3 |
| Shares Change (YoY) | 25.11% | 1.96% | 203.94% | 793.58% | -41.81% | - |
| EPS (Basic) | -1.57 | -1.62 | -1.32 | -1.91 | -6.05 | -1.53 |
| EPS (Diluted) | -1.57 | -1.62 | -1.32 | -1.91 | -6.05 | -1.53 |
| Free Cash Flow | -64.98 | -50.91 | -50.84 | -24.41 | -8.08 | -2.64 |
| Free Cash Flow Per Share | -1.22 | -1.19 | -1.21 | -1.77 | -5.24 | -1.00 |
| EBITDA | -99.59 | -79.59 | -58.63 | -26.15 | -9.25 | -3.11 |
| D&A For EBITDA | 0.47 | 0.35 | 0.3 | 0.14 | 0.05 | 0.01 |
| EBIT | -100.07 | -79.95 | -58.93 | -26.29 | -9.3 | -3.12 |
Source: S&P Capital IQ. Standard template.
Financial Sources.